Here are relevant reports on : automotive-diagnostic-market
-
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecast to 2020
The global qPCR reagents market size is projected to grow at a CAGR of 7.7%. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Ophthalmic Diagnostic and Surgical Devices Market (2012-2017)
The report studies the ophthalmology devices market by diagnostic devices and surgical devices. This market is expected to witness significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Wireless Implantable Diagnostic Devices Market - 2019 By Types, Application & Geography
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics) & Region - Global Forecast to 2026
The global influenza diagnostics market growth is primed to transition from $0.8 billion in 2021 to $1.1 billion by 2026, showcasing a strong CAGR of 7.7%. Key factors driving this growth include increasing demand for rapid disease diagnosis, rising influenza prevalence, and advancements in diagnostic technologies.
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centres) & Region - Global Forecast to 2027
The global needles market growth is primed to transition from billion USD 7.7 in 2022 to USD 10.6 billion by 2027, showcasing a strong CAGR of 6.7%. The expansion of this market is majorly due to upsurging cases of chronic diseases such as cancer, HIV as well as growing elderly population. However, Growing focus on core development of substitute drug delivery methods is one of the challenge for which may inhibit the growth of this market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029
The global oligonucleotide CDMO market, valued at US$2.33 billion in 2023, stood at US$2.51 billion in 2024 and is projected to advance at a resilient CAGR of 21.8% from 2024 to 2029, culminating in a forecasted valuation of US$6.73 billion by the end of the period. The increasing focus on precision/personalized medicine is also likely to contribute to market growth. Growing opportunities offered by emerging economies are accelerating innovation in the oligonucleotide CDMO field.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030
The global clinical microbiology market, valued at US$5.08 billion in 2024, stood at US$5.33 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$7.34 billion by the end of the period. A key factor contributing to market growth is the rising technological advancements that have enabled the development of advanced microbial identification methods and improved antibiotic susceptibility testing.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Rolling Stock Management Market by Management (Rail, Infrastructure), Rail (Remote Diagnostic, Wayside, Train, Asset, Cab Advisory), Infrastructure (Control Room, Station, Automatic Fare Collection), Maintenance Service & Region - Global Forecast to 2025
The global rolling stock management market is projected to grow from USD 42.8 billion in 2019 to reach USD 58.4 billion by 2025, at a CAGR of 5.32%. The rising concerns over safety, security, inspection, maintenance, and in the transport business has led to the growth of the rolling stock management market. It not only includes the fact of reducing long term cost but also mitigating the traditional methods of maintenance. Transport can be through the medium of air, road, or train but its efficiency and effect on the environment. The emerging nations support railways as a well-suited means of mass transport for passengers and freight.Bombardier (Canada), Alstom (France), General Electric (US), and Siemens (Germany).
- Published: March 2019
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
